Endocrinology

New Study Finds No Thyroid Cancer Risk from GLP1 An image depicting Scandinavian healthcare data analysis involving patients and doctors, with a digital overlay showcasing medical records and cancer research in a modern clinical setting. The background shows serene Nordic landscapes with medical facilities and people representing different age groups, signifying population health studies.

An image depicting Scandinavian healthcare data analysis involving patients and doctors, with a digital overlay showcasing medical records and cancer research in a modern clinical setting. The background shows serene Nordic landscapes with medical facilities and people representing different age groups, signifying population health studies.

New Study Finds No Thyroid Cancer Risk from GLP1

Contributor September 25, 2024

This Scandinavian cohort study analyzed the potential link between GLP1 receptor agonists, used in type 2 diabetes...

Life-Saving Drug Combo Lowers Heart and Kidney Risks by 30% Image of a medical study concept showing pills, heart symbols, and kidneys connected by a flow of vibrant, glowing energy. Emphasizing the powerful connection between diabetes medication and improved cardiovascular and renal health, set against a backdrop of dynamic medical data visualization.

Image of a medical study concept showing pills, heart symbols, and kidneys connected by a flow of vibrant, glowing energy. Emphasizing the powerful connection between diabetes medication and improved cardiovascular and renal health, set against a backdrop of dynamic medical data visualization.

Life-Saving Drug Combo Lowers Heart and Kidney Risks by 30%

Contributor September 25, 2024

This study assesses whether combining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT-2 inhibitors)...

SGLT-2 Inhibitors Outperform in Diabetes Care An insightful doctor prescribing advanced treatments for type 2 diabetes, comparing various drug therapies in a clinical setting. Emphasis on SGLT-2 inhibitors, with medical charts showing lower blood sugar levels and improvements in heart and kidney health. A scene showing patient progress with cutting-edge diabetes management.

An insightful doctor prescribing advanced treatments for type 2 diabetes, comparing various drug therapies in a clinical setting. Emphasis on SGLT-2 inhibitors, with medical charts showing lower blood sugar levels and improvements in heart and kidney health. A scene showing patient progress with cutting-edge diabetes management.

SGLT-2 Inhibitors Outperform in Diabetes Care

Contributor September 25, 2024

This study compares the effectiveness of second-line oral antidiabetic treatments in people with type 2 diabetes. SGLT-2...

Global Diabetes Rise: Surprising Truths for Older Adults An elderly person with Type 1 diabetes, standing in a medical setting with charts showing rising prevalence of diabetes, surrounded by futuristic medical devices and care equipment, highlighting disparities in healthcare access across different regions of the world.

An elderly person with Type 1 diabetes, standing in a medical setting with charts showing rising prevalence of diabetes, surrounded by futuristic medical devices and care equipment, highlighting disparities in healthcare access across different regions of the world.

Global Diabetes Rise: Surprising Truths for Older Adults

Contributor September 23, 2024

The study highlights the increasing global burden of Type 1 diabetes (T1DM) among adults aged 65 and...

Cutting Potassium Risk: A Breakthrough for Diabetes Patients High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

Cutting Potassium Risk: A Breakthrough for Diabetes Patients

Contributor September 23, 2024

This population-based cohort study investigates the relationship between the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and...

Discover the Powerful Link Between Diabetes and Dementia Prevention A medical study scene showing two types of diabetes medication (SGLT-2 inhibitors vs. DPP-4 inhibitors) influencing brain health. The image should depict brain protection, neurons, and a futuristic approach to dementia prevention. Clear elements of healthcare, diabetes, and cognitive science.

A medical study scene showing two types of diabetes medication (SGLT-2 inhibitors vs. DPP-4 inhibitors) influencing brain health. The image should depict brain protection, neurons, and a futuristic approach to dementia prevention. Clear elements of healthcare, diabetes, and cognitive science.

Discover the Powerful Link Between Diabetes and Dementia Prevention

Contributor September 21, 2024

The study compares dementia risk in adults aged 40-69 with type 2 diabetes, following the use of...

Unlocking Hidden Risks: Fatty Liver and Heart Disease in Diabetes Depicting a patient with type 2 diabetes, focusing on the heart and liver to represent cardiovascular disease and non-alcoholic fatty liver disease.

Depicting a patient with type 2 diabetes, focusing on the heart and liver to represent cardiovascular disease and non-alcoholic fatty liver disease.

Unlocking Hidden Risks: Fatty Liver and Heart Disease in Diabetes

Contributor September 20, 2024

This study investigates the relationship between non-alcoholic fatty liver disease (NAFLD) and the risk of cardiovascular disease...

Unlock Superior Diabetes Control: Boost Health & Confidence An advanced medical illustration showcasing the mechanism of GLP-1 receptor agonists in type 2 diabetes treatment. The image should depict a vibrant scientific scene with blood sugar regulation, weight loss, and lipid improvement visual cues, all in a clinical setting.

Unlock Superior Diabetes Control: Boost Health & Confidence

Contributor September 18, 2024

This systematic review and meta-analysis evaluates the comparative effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) for glycemic...

Sugar Beverage Epidemic in Youth: Dire Global Impact Unveiled An urban scene showing a diverse group of children drinking sugar-laden sodas against the backdrop of a cityscape with billboards advertising sugary drinks. The atmosphere is busy, with children holding oversized sugar-filled beverage cups, conveying the scale of the consumption crisis. Bright neon colors to contrast with the serious tone of a health emergency unfolding.

An urban scene showing a diverse group of children drinking sugar-laden sodas against the backdrop of a cityscape with billboards advertising sugary drinks. The atmosphere is busy, with children holding oversized sugar-filled beverage cups, conveying the scale of the consumption crisis. Bright neon colors to contrast with the serious tone of a health emergency unfolding.

Sugar Beverage Epidemic in Youth: Dire Global Impact Unveiled

Contributor September 17, 2024

The consumption of sugar-sweetened beverages among children and adolescents has escalated to alarming levels worldwide. A new...

Alarming Retinopathy Surge in Early-Onset Type 2 Diabetes: Gender Insights Concerned young adult, with noticeable signs of eye strain and diabetes complications, looking into a mirror. The scene is set in a dimly lit, modern clinic with a medical poster on diabetes in the background, highlighting eye complications. The expression should evoke urgency and health concern.